Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2001 by Aarhus University Hospital Skejby.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Regional Hospital Holstebro
Aarhus University Hospital
Information provided by:
Aarhus University Hospital Skejby
ClinicalTrials.gov Identifier:
NCT00317928
First received: April 24, 2006
Last updated: October 10, 2006
Last verified: August 2001
  Purpose

Hypothesis: Metformin treatment normalises hormone values and metabolic parameters in women with PCOS. Ovulation is restored and bleeding periods become regular.

Fifty women with PCOS (Rotterdam criteria) are randomised to either placebo or metformin for 6 months. After a wash-out period of 3 months, the opposite treatment is given for another 6 months. Measurements are performed before ech treatment period, every second month during treatment and after completing treatment.


Condition Intervention
Polycystic Ovary Syndrome
Drug: Metformin

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double-Blind
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Aarhus University Hospital Skejby:

Estimated Enrollment: 50
Study Start Date: August 2001
Estimated Study Completion Date: September 2004
  Eligibility

Ages Eligible for Study:   20 Years to 45 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of PCOS
  • Age 20 - 45

Exclusion Criteria:Diabetes

  • Diabetes
  • Hormonal treatment
  • Pregnancy, lactation
  • Periclimacteric
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00317928

Sponsors and Collaborators
Aarhus University Hospital Skejby
Regional Hospital Holstebro
Aarhus University Hospital
Investigators
Principal Investigator: Ditte Trolle, MD Skejby University Hospital, Aarhus, Denmark
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00317928     History of Changes
Other Study ID Numbers: 160350-1
Study First Received: April 24, 2006
Last Updated: October 10, 2006
Health Authority: Denmark: Ministry of Health

Keywords provided by Aarhus University Hospital Skejby:
Polycystic Ovary Syndrome
Metformin
Metabolic Syndrome
Hyperandrogenism
Ovulation

Additional relevant MeSH terms:
Polycystic Ovary Syndrome
Syndrome
Adnexal Diseases
Cysts
Disease
Endocrine System Diseases
Genital Diseases, Female
Gonadal Disorders
Neoplasms
Ovarian Cysts
Ovarian Diseases
Pathologic Processes
Metformin
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on October 23, 2014